# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-165712
Filing Date
2024-06-21
Accepted
2024-06-21 16:23:28
Documents
7
Period of Report
2024-08-06

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d802241ddef14a.htm | DEF 14A | 1281698
2 | GRAPHIC | g802241g00r01.jpg | GRAPHIC | 25425
3 | GRAPHIC | g802241g00r41.jpg | GRAPHIC | 43591
4 | GRAPHIC | g802241g00r42.jpg | GRAPHIC | 42819
5 | GRAPHIC | g802241g01l07.jpg | GRAPHIC | 25741
6 | GRAPHIC | g802241g19p19.jpg | GRAPHIC | 224220
7 | GRAPHIC | g802241g20p20.jpg | GRAPHIC | 316366
| Complete submission text file | 0001193125-24-165712.txt |  | 2216790

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37627 | Film No.: 241060748
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)